<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37721955</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7374</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>PLoS pathogens</Title><ISOAbbreviation>PLoS Pathog</ISOAbbreviation></Journal><ArticleTitle>The development of resistance to an inhibitor of a cellular protein reveals a critical interaction between the enterovirus protein 2C and a small GTPase Arf1.</ArticleTitle><Pagination><StartPage>e1011673</StartPage><MedlinePgn>e1011673</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1011673</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1011673</ELocationID><Abstract><AbstractText>The cellular protein GBF1, an activator of Arf GTPases (ArfGEF: Arf guanine nucleotide exchange factor), is recruited to the replication organelles of enteroviruses through interaction with the viral protein 3A, and its ArfGEF activity is required for viral replication, however how GBF1-dependent Arf activation supports the infection remains enigmatic. Here, we investigated the development of resistance of poliovirus, a prototype enterovirus, to increasing concentrations of brefeldin A (BFA), an inhibitor of GBF1. High level of resistance required a gradual accumulation of multiple mutations in the viral protein 2C. The 2C mutations conferred BFA resistance even in the context of a 3A mutant previously shown to be defective in the recruitment of GBF1 to replication organelles, and in cells depleted of GBF1, suggesting a GBF1-independent replication mechanism. Still, activated Arfs accumulated on the replication organelles of this mutant even in the presence of BFA, its replication was inhibited by a pan-ArfGEF inhibitor LM11, and the BFA-resistant phenotype was compromised in Arf1-knockout cells. Importantly, the mutations strongly increased the interaction of 2C with the activated form of Arf1. Analysis of other enteroviruses revealed a particularly strong interaction of 2C of human rhinovirus 1A with activated Arf1. Accordingly, the replication of this virus was significantly less sensitive to BFA than that of poliovirus. Thus, our data demonstrate that enterovirus 2Cs may behave like Arf1 effector proteins and that GBF1 but not Arf activation can be dispensable for enterovirus replication. These findings have important implications for the development of host-targeted anti-viral therapeutics.</AbstractText><CopyrightInformation>Copyright: © 2023 Viktorova et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Viktorova</LastName><ForeName>Ekaterina G</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Department of Veterinary Medicine and Virginia-Maryland College of Veterinary Medicine, University of Maryland, College Park, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabaglio</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Veterinary Medicine and Virginia-Maryland College of Veterinary Medicine, University of Maryland, College Park, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moghimi</LastName><ForeName>Seyedehmahsa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Veterinary Medicine and Virginia-Maryland College of Veterinary Medicine, University of Maryland, College Park, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zimina</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Veterinary Medicine and Virginia-Maryland College of Veterinary Medicine, University of Maryland, College Park, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wynn</LastName><ForeName>Bridge G</ForeName><Initials>BG</Initials><AffiliationInfo><Affiliation>Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham; Birmingham, Alabama, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sztul</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham; Birmingham, Alabama, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belov</LastName><ForeName>George A</ForeName><Initials>GA</Initials><Identifier Source="ORCID">0000-0002-0892-1731</Identifier><AffiliationInfo><Affiliation>Department of Veterinary Medicine and Virginia-Maryland College of Veterinary Medicine, University of Maryland, College Park, Maryland, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI125561</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI169458</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM122802</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Pathog</MedlineTA><NlmUniqueID>101238921</NlmUniqueID><ISSNLinking>1553-7366</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.6.5.2</RegistryNumber><NameOfSubstance UI="D020559">Monomeric GTP-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.5.2</RegistryNumber><NameOfSubstance UI="D020823">ADP-Ribosylation Factor 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>20350-15-6</RegistryNumber><NameOfSubstance UI="D020126">Brefeldin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C120445">GBF1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020662">Guanine Nucleotide Exchange Factors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020559" MajorTopicYN="Y">Monomeric GTP-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020823" MajorTopicYN="N">ADP-Ribosylation Factor 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020126" MajorTopicYN="N">Brefeldin A</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020662" MajorTopicYN="N">Guanine Nucleotide Exchange Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>18</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>18</Day><Hour>13</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37721955</ArticleId><ArticleId IdType="pmc">PMC10538752</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1011673</ArticleId><ArticleId IdType="pii">PPATHOGENS-D-23-00867</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tang JW, Holmes CW. Acute and chronic disease caused by enteroviruses. Virulence. 2017;8(7):1062–5. doi: 10.1080/21505594.2017.1308620</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2017.1308620</ArticleId><ArticleId IdType="pmc">PMC5711444</ArticleId><ArticleId IdType="pubmed">28362547</ArticleId></ArticleIdList></Reference><Reference><Citation>Minor P. The polio endgame. Hum Vaccin Immunother. 2014;10(7):2106–8. doi: 10.4161/21645515.2014.981115</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/21645515.2014.981115</ArticleId><ArticleId IdType="pmc">PMC4370356</ArticleId><ArticleId IdType="pubmed">25608050</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed Z, Cardosa MJ. Status of research and development of vaccines for enterovirus 71. Vaccine. 2016;34(26):2967–70. doi: 10.1016/j.vaccine.2016.02.077</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2016.02.077</ArticleId><ArticleId IdType="pubmed">26973065</ArticleId></ArticleIdList></Reference><Reference><Citation>Benschop KSM, Van der Avoort HGAM, Duizer E, Koopmans MPG. Antivirals against enteroviruses: a critical review from a public-health perspective. Antivir Ther. 2015;20(2):121–30. doi: 10.3851/IMP2939</Citation><ArticleIdList><ArticleId IdType="doi">10.3851/IMP2939</ArticleId><ArticleId IdType="pubmed">25643052</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L, Lyoo H, van der Schaar HM, Strating JRPM, van Kuppeveld FJM. Direct-acting antivirals and host-targeting strategies to combat enterovirus infections. Curr Opin Virol. 2017;24:1–8. doi: 10.1016/j.coviro.2017.03.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2017.03.009</ArticleId><ArticleId IdType="pmc">PMC7172203</ArticleId><ArticleId IdType="pubmed">28411509</ArticleId></ArticleIdList></Reference><Reference><Citation>Bienz K, Egger D, Rasser Y, Bossart W. Intracellular distribution of poliovirus proteins and the induction of virus-specific cytoplasmic structures. Virology. 1983;131(1):39–48. doi: 10.1016/0042-6822(83)90531-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(83)90531-7</ArticleId><ArticleId IdType="pubmed">6316654</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu NY, Ilnytska O, Belov G, Santiana M, Chen YH, Takvorian PM, et al.. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell. 2010;141(5):799–811. doi: 10.1016/j.cell.2010.03.050</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.03.050</ArticleId><ArticleId IdType="pmc">PMC2982146</ArticleId><ArticleId IdType="pubmed">20510927</ArticleId></ArticleIdList></Reference><Reference><Citation>Belov GA, Nair V, Hansen BT, Hoyt FH, Fischer ER, Ehrenfeld E. Complex Dynamic Development of Poliovirus Membranous Replication Complexes. J Virol. 2012;86(1):302–12. doi: 10.1128/JVI.05937-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05937-11</ArticleId><ArticleId IdType="pmc">PMC3255921</ArticleId><ArticleId IdType="pubmed">22072780</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhat R, Ankavay M, Lebsir N, Gouttenoire J, Jackson CL, Wychowski C, et al.. Identification of GBF1 as a cellular factor required for hepatitis E virus RNA replication. Cell Microbiol. 2018;20(1). doi: 10.1111/cmi.12804</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cmi.12804</ArticleId><ArticleId IdType="pmc">PMC7162332</ArticleId><ArticleId IdType="pubmed">29112323</ArticleId></ArticleIdList></Reference><Reference><Citation>Verheije MH, Raaben M, Mari M, Lintelo EGT, Reggiori F, van Kuppeveld FJM, et al.. Mouse hepatitis coronavirus RNA replication depends on GBF1-mediated ARF1 activation. Plos Pathog. 2008;4(6). doi: 10.1371/journal.ppat.1000088</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000088</ArticleId><ArticleId IdType="pmc">PMC2398782</ArticleId><ArticleId IdType="pubmed">18551169</ArticleId></ArticleIdList></Reference><Reference><Citation>Goueslain L, Alsaleh K, Horellou P, Roingeard P, Descamps V, Duverlie G, et al.. Identification of GBF1 as a Cellular Factor Required for Hepatitis C Virus RNA Replication. J Virol. 2010;84(2):773–87. doi: 10.1128/JVI.01190-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01190-09</ArticleId><ArticleId IdType="pmc">PMC2798365</ArticleId><ArticleId IdType="pubmed">19906930</ArticleId></ArticleIdList></Reference><Reference><Citation>Belov GA, Feng Q, Nikovics K, Jackson CL, Ehrenfeld E. A Critical Role of a Cellular Membrane Traffic Protein in Poliovirus RNA Replication. Plos Pathog. 2008;4(11). doi: 10.1371/journal.ppat.1000216</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000216</ArticleId><ArticleId IdType="pmc">PMC2581890</ArticleId><ArticleId IdType="pubmed">19023417</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanke KH, van der Schaar HM, Belov GA, Feng Q, Duijsings D, Jackson CL, et al.. GBF1, a guanine nucleotide exchange factor for Arf, is crucial for coxsackievirus B3 RNA replication. J Virol. 2009;83(22):11940–9. doi: 10.1128/JVI.01244-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01244-09</ArticleId><ArticleId IdType="pmc">PMC2772713</ArticleId><ArticleId IdType="pubmed">19740986</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanova JE. Regulation of arf activation: the sec7 family of guanine nucleotide exchange factors. Traffic. 2007;8(11):1476–85. doi: 10.1111/j.1600-0854.2007.00634.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0854.2007.00634.x</ArticleId><ArticleId IdType="pubmed">17850229</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie ZZ, Hirsch DS, Randazzo PA. Arf and its many interactors. Curr Opin Cell Biol. 2003;15(4):396–404. doi: 10.1016/s0955-0674(03)00071-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0955-0674(03)00071-1</ArticleId><ArticleId IdType="pubmed">12892779</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaczmarek B, Verbavatz JM, Jackson CL. GBF1 and Arf1 function in vesicular trafficking, lipid homoeostasis and organelle dynamics. Biol Cell. 2017;109(12):391–9. doi: 10.1111/boc.201700042</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/boc.201700042</ArticleId><ArticleId IdType="pubmed">28985001</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouvet S, Golinelli-Cohen MP, Contremoulins V, Jackson CL. Targeting of the Arf-GEF GBF1 to lipid droplets and Golgi membranes. J Cell Sci. 2013;126(20):4794–805. doi: 10.1242/jcs.134254</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.134254</ArticleId><ArticleId IdType="pubmed">23943872</ArticleId></ArticleIdList></Reference><Reference><Citation>Soni KG, Mardones GA, Sougrat R, Smirnova E, Jackson CL, Bonifacino JS. Coatomer-dependent protein delivery to lipid droplets. J Cell Sci. 2009;122(11):1834–41. doi: 10.1242/jcs.045849</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.045849</ArticleId><ArticleId IdType="pmc">PMC2684835</ArticleId><ArticleId IdType="pubmed">19461073</ArticleId></ArticleIdList></Reference><Reference><Citation>Meissner JM, Bhatt JM, Lee E, Styers ML, Ivanova AA, Kahn RA, et al.. The ARF guanine nucleotide exchange factor GBF1 is targeted to Golgi membranes through a PIP-binding domain. J Cell Sci. 2018;131(3). doi: 10.1242/jcs.210245</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.210245</ArticleId><ArticleId IdType="pmc">PMC5826047</ArticleId><ArticleId IdType="pubmed">29361542</ArticleId></ArticleIdList></Reference><Reference><Citation>Walton K, Leier A, Sztul E. Regulating the regulators: role of phosphorylation in modulating the function of the GBF1/BIG family of Sec7 ARF-GEFs. Febs Lett. 2020;594(14):2213–26. doi: 10.1002/1873-3468.13798</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.13798</ArticleId><ArticleId IdType="pubmed">32333796</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright J, Kahn RA, Sztul E. Regulating the large Sec7 ARF guanine nucleotide exchange factors: the when, where and how of activation. Cell Mol Life Sci. 2014;71(18):3419–38. doi: 10.1007/s00018-014-1602-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-014-1602-7</ArticleId><ArticleId IdType="pmc">PMC4861048</ArticleId><ArticleId IdType="pubmed">24728583</ArticleId></ArticleIdList></Reference><Reference><Citation>Sata M, Donaldson JG, Moss J, Vaughan M. Brefeldin A-inhibited guanine nucleotide-exchange activity of Sec7 domain from yeast Sec7 with yeast and mammalian ADP ribosylation factors. P Natl Acad Sci USA. 1998;95(8):4204–8. doi: 10.1073/pnas.95.8.4204</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.8.4204</ArticleId><ArticleId IdType="pmc">PMC22466</ArticleId><ArticleId IdType="pubmed">9539714</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CL, Casanova JE. Turning on ARF: the Sec7 family of guanine-nucleotide-exchange factors. Trends Cell Biol. 2000;10(2):60–7. doi: 10.1016/s0962-8924(99)01699-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0962-8924(99)01699-2</ArticleId><ArticleId IdType="pubmed">10652516</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan HL, Yu J, Zhang LH, Carpenter A, Zhu H, Li L, et al.. A Novel Small Molecule Regulator of Guanine Nucleotide Exchange Activity of the ADP-ribosylation Factor and Golgi Membrane Trafficking. J Biol Chem. 2008;283(45):31087–96. doi: 10.1074/jbc.M806592200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M806592200</ArticleId><ArticleId IdType="pmc">PMC2576541</ArticleId><ArticleId IdType="pubmed">18799457</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco-Rodriguez G, Moss J, Vaughan M. Isolation, cloning, and characterization of brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factor. Methods Enzymol. 2001;329:300–6. doi: 10.1016/s0076-6879(01)29091-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0076-6879(01)29091-0</ArticleId><ArticleId IdType="pubmed">11210548</ArticleId></ArticleIdList></Reference><Reference><Citation>Morinaga N, Tsai SC, Moss J, Vaughan M. Isolation of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP ribosylation factor (ARF) 1 and ARF3 that contains a Sec7-like domain. Proc Natl Acad Sci U S A. 1996;93(23):12856–60. doi: 10.1073/pnas.93.23.12856</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.23.12856</ArticleId><ArticleId IdType="pmc">PMC24010</ArticleId><ArticleId IdType="pubmed">8917509</ArticleId></ArticleIdList></Reference><Reference><Citation>Morinaga N, Moss J, Vaughan M. Cloning and expression of a cDNA encoding a bovine brain brefeldin A-sensitive guanine nucleotide-exchange protein for ADP-ribosylation factor. Proc Natl Acad Sci U S A. 1997;94(24):12926–31. doi: 10.1073/pnas.94.24.12926</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.94.24.12926</ArticleId><ArticleId IdType="pmc">PMC24240</ArticleId><ArticleId IdType="pubmed">9371777</ArticleId></ArticleIdList></Reference><Reference><Citation>Peyroche A, Antonny B, Robineau S, Acker J, Cherfils J, Jackson CL. Brefeldin A acts to stabilize an abortive ARF-GDP-Sec7 domain protein complex: involvement of specific residues of the Sec7 domain. Mol Cell. 1999;3(3):275–85. doi: 10.1016/s1097-2765(00)80455-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1097-2765(00)80455-4</ArticleId><ArticleId IdType="pubmed">10198630</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu TK, Pfeifer AC, Lippincott-Schwartz J, Jackson CL. Dynamics of GBF1, a brefeldin A-sensitive Arf1 exchange factor at the Golgi. Mol Biol Cell. 2005;16(3):1213–22. doi: 10.1091/mbc.e04-07-0599</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e04-07-0599</ArticleId><ArticleId IdType="pmc">PMC551486</ArticleId><ArticleId IdType="pubmed">15616190</ArticleId></ArticleIdList></Reference><Reference><Citation>Sztul E, Chen PW, Casanova JE, Cherfils J, Decks JB, Lambright DG, et al.. ARF GTPases and their GEFs and GAPs: concepts and challenges. Mol Biol Cell. 2019;30(11):1249–71. doi: 10.1091/mbc.E18-12-0820</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E18-12-0820</ArticleId><ArticleId IdType="pmc">PMC6724607</ArticleId><ArticleId IdType="pubmed">31084567</ArticleId></ArticleIdList></Reference><Reference><Citation>Saenz JB, Sun WJ, Chang JW, Li J, Bursulaya B, Gray NS, et al.. Golgicide A reveals essential roles for GBF1 in Golgi assembly and function. Nat Chem Biol. 2009;5(3):157–65. doi: 10.1038/nchembio.144</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.144</ArticleId><ArticleId IdType="pmc">PMC3500152</ArticleId><ArticleId IdType="pubmed">19182783</ArticleId></ArticleIdList></Reference><Reference><Citation>Viaud J, Zeghouf M, Barelli H, Zeeh JC, Padilla A, Guibert B, et al.. Structure-based discovery of an inhibitor of Arf activation by Sec7 domains through targeting of protein-protein complexes. Proc Natl Acad Sci U S A. 2007;104(25):10370–5. doi: 10.1073/pnas.0700773104</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0700773104</ArticleId><ArticleId IdType="pmc">PMC1965520</ArticleId><ArticleId IdType="pubmed">17563369</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghimi S, Viktorova E, Zimina A, Szul T, Sztul E, Belov GA. Enterovirus Infection Induces Massive Recruitment of All Isoforms of Small Cellular Arf GTPases to the Replication Organelles. J Virol. 2020;95(2).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7944459</ArticleId><ArticleId IdType="pubmed">33087467</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels E, Duijsings D, Lanke KHW, Melchers WJG, Jackson CL, van Kuppeveld FJM. Molecular determinants of the interaction between coxsackievirus protein 3A and guanine nucleotide exchange factor GBF1. J Virol. 2007;81(10):5238–45. doi: 10.1128/JVI.02680-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02680-06</ArticleId><ArticleId IdType="pmc">PMC1900206</ArticleId><ArticleId IdType="pubmed">17329336</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Linden L, van der Schaar HM, Lanke KHW, Neyts J, van Kuppeveld FJM. Differential Effects of the Putative GBF1 Inhibitors Golgicide A and AG1478 on Enterovirus Replication. J Virol. 2010;84(15):7535–42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2897619</ArticleId><ArticleId IdType="pubmed">20504936</ArticleId></ArticleIdList></Reference><Reference><Citation>Viktorova EG, Gabaglio S, Meissner JM, Lee E, Moghimi S, Sztul E, et al.. A Redundant Mechanism of Recruitment Underlies the Remarkable Plasticity of the Requirement of Poliovirus Replication for the Cellular ArfGEF GBF1. J Virol. 2019;93(21). doi: 10.1128/JVI.00856-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00856-19</ArticleId><ArticleId IdType="pmc">PMC6803275</ArticleId><ArticleId IdType="pubmed">31375590</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotty S, Saleh MC, Gitlin L, Beske O, Andino R. The poliovirus replication machinery can escape inhibition by an antiviral drug that targets a host cell protein. J Virol. 2004;78(7):3378–86. doi: 10.1128/jvi.78.7.3378-3386.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.78.7.3378-3386.2004</ArticleId><ArticleId IdType="pmc">PMC371039</ArticleId><ArticleId IdType="pubmed">15016860</ArticleId></ArticleIdList></Reference><Reference><Citation>Viktorova EG, Nchoutmboube J, Ford-Siltz LA, Belov GA. Cell-Specific Establishment of Poliovirus Resistance to an Inhibitor Targeting a Cellular Protein. J Virol. 2015;89(8):4372–86. doi: 10.1128/JVI.00055-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00055-15</ArticleId><ArticleId IdType="pmc">PMC4442370</ArticleId><ArticleId IdType="pubmed">25653442</ArticleId></ArticleIdList></Reference><Reference><Citation>Belov GA, Kovtunovych G, Jackson CL, Ehrenfeld E. Poliovirus replication requires the N-terminus but not the catalytic Sec7 domain of ArfGEF GBF1. Cell Microbiol. 2010;12(10):1463–79. doi: 10.1111/j.1462-5822.2010.01482.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-5822.2010.01482.x</ArticleId><ArticleId IdType="pmc">PMC2945620</ArticleId><ArticleId IdType="pubmed">20497182</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennauer M, Buczak K, Prescianotto-Baschong C, Spiess M. Shared and specific functions of Arfs 1–5 at the Golgi revealed by systematic knockouts. J Cell Biol. 2022;221(1). doi: 10.1083/jcb.202106100</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.202106100</ArticleId><ArticleId IdType="pmc">PMC8579194</ArticleId><ArticleId IdType="pubmed">34749397</ArticleId></ArticleIdList></Reference><Reference><Citation>Belov GA, Fogg MH, Ehrenfeld E. Poliovirus proteins induce membrane association of GTPase ADP-ribosylation factor. J Virol. 2005;79(11):7207–16. doi: 10.1128/JVI.79.11.7207-7216.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.11.7207-7216.2005</ArticleId><ArticleId IdType="pmc">PMC1112117</ArticleId><ArticleId IdType="pubmed">15890959</ArticleId></ArticleIdList></Reference><Reference><Citation>Viktorova EG, Khattar S, Samal S, Belov GA. Poliovirus Replicon RNA Generation, Transfection, Packaging, and Quantitation of Replication. Curr Protoc Microbiol. 2018;48:15H 4 1-H 4 doi: 10.1002/cpmc.47</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpmc.47</ArticleId><ArticleId IdType="pmc">PMC5844361</ArticleId><ArticleId IdType="pubmed">29512114</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasamontes L, Egger D, Bienz K. Production of monoclonal and monospecific antibodies against non-capsid proteins of poliovirus. J Gen Virol. 1986;67 (Pt 11):2415–22. doi: 10.1099/0022-1317-67-11-2415</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-67-11-2415</ArticleId><ArticleId IdType="pubmed">2431100</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafiq NB, Lieu ZZ, Jiang T, Yu CH, Matsudaira P, Jones GE, et al.. Podosome assembly is controlled by the GTPase ARF1 and its nucleotide exchange factor ARNO. J Cell Biol. 2017;216(1):181–97. doi: 10.1083/jcb.201605104</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201605104</ArticleId><ArticleId IdType="pmc">PMC5223603</ArticleId><ArticleId IdType="pubmed">28007915</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh SJ, Santy LC. Differential effects of cytohesins 2 and 3 on beta1 integrin recycling. J Biol Chem. 2010;285(19):14610–6. doi: 10.1074/jbc.M109.043935</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.043935</ArticleId><ArticleId IdType="pmc">PMC2863229</ArticleId><ArticleId IdType="pubmed">20223830</ArticleId></ArticleIdList></Reference><Reference><Citation>Moravec R, Conger KK, D’Souza R, Allison AB, Casanova JE. BRAG2/GEP100/IQSec1 interacts with clathrin and regulates alpha5beta1 integrin endocytosis through activation of ADP ribosylation factor 5 (Arf5). J Biol Chem. 2012;287(37):31138–47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3438945</ArticleId><ArticleId IdType="pubmed">22815487</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinze SJ, Jackson MR, Lie S, Jolly L, Field M, Barry SC, et al.. Incorrect dosage of IQSEC2, a known intellectual disability and epilepsy gene, disrupts dendritic spine morphogenesis. Transl Psychiatry. 2017;7(5):e1110. doi: 10.1038/tp.2017.81</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/tp.2017.81</ArticleId><ArticleId IdType="pmc">PMC5534949</ArticleId><ArticleId IdType="pubmed">28463240</ArticleId></ArticleIdList></Reference><Reference><Citation>Montagnac G, Sibarita JB, Loubery S, Daviet L, Romao M, Raposo G, et al.. ARF6 Interacts with JIP4 to Control a Motor Switch Mechanism Regulating Endosome Traffic in Cytokinesis. Curr Biol. 2009;19(3):184–95. doi: 10.1016/j.cub.2008.12.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2008.12.043</ArticleId><ArticleId IdType="pubmed">19211056</ArticleId></ArticleIdList></Reference><Reference><Citation>Tse YC, Lo SW, Hillmer S, Dupree P, Jiang LW. Dynamic response of prevacuolar compartments to brefeldin A in plant cells. Plant Physiol. 2006;142(4):1442–59. doi: 10.1104/pp.106.090423</Citation><ArticleIdList><ArticleId IdType="doi">10.1104/pp.106.090423</ArticleId><ArticleId IdType="pmc">PMC1676059</ArticleId><ArticleId IdType="pubmed">17041023</ArticleId></ArticleIdList></Reference><Reference><Citation>Nebenfuhr A, Ritzenthaler C, Robinson DG. Brefeldin A: Deciphering an enigmatic inhibitor of secretion. Plant Physiol. 2002;130(3):1102–8. doi: 10.1104/pp.011569</Citation><ArticleIdList><ArticleId IdType="doi">10.1104/pp.011569</ArticleId><ArticleId IdType="pmc">PMC1540261</ArticleId><ArticleId IdType="pubmed">12427977</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Kim H, Ko D, Yamaoka Y, Otsuru M, Kawai-Yamada M, et al.. Rapid Induction of Lipid Droplets in Chlamydomonas reinhardtii and Chlorella vulgaris by Brefeldin A. Plos One. 2013;8(12). doi: 10.1371/journal.pone.0081978</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0081978</ArticleId><ArticleId IdType="pmc">PMC3862487</ArticleId><ArticleId IdType="pubmed">24349166</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso M, Burgos HI, Pannunzio V, Hughes AM, Mattoon JR, Stella CA. Brefeldin a decreases the activity of the general amino acid permease (GAP1) and the more specific systems for L-leucine uptake in Saccharomyces cerevisiae. Cell Mol Biol Lett. 2006;11(2):256–63. doi: 10.2478/s11658-006-0020-8</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/s11658-006-0020-8</ArticleId><ArticleId IdType="pmc">PMC6275790</ArticleId><ArticleId IdType="pubmed">16847570</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritzenthaler C, Nebenfuhr A, Movafeghi A, Stussi-Garaud C, Behnia L, Pimpl P, et al.. Reevaluation of the effects of brefeldin A on plant cells using tobacco bright yellow 2 cells expressing Golgi-targeted green fluorescent protein and COPI antisera. Plant Cell. 2002;14(1):237–61. doi: 10.1105/tpc.010237</Citation><ArticleIdList><ArticleId IdType="doi">10.1105/tpc.010237</ArticleId><ArticleId IdType="pmc">PMC150562</ArticleId><ArticleId IdType="pubmed">11826310</ArticleId></ArticleIdList></Reference><Reference><Citation>Echeverri AC, Dasgupta A. Amino terminal regions of poliovirus 2C protein mediate membrane binding. Virology. 1995;208(2):540–53. doi: 10.1006/viro.1995.1185</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1995.1185</ArticleId><ArticleId IdType="pubmed">7747426</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul AV, Molla A, Wimmer E. Studies of a putative amphipathic helix in the N-terminus of poliovirus protein 2C. Virology. 1994;199(1):188–99. doi: 10.1006/viro.1994.1111</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1994.1111</ArticleId><ArticleId IdType="pubmed">8116242</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Bigay J. Poliovirus Evolution toward Independence from the Phosphatidylinositol-4 Kinase III beta/Oxysterol-Binding Protein Family I Pathway. ACS Infect Dis. 2019;5(6):962–73.</Citation><ArticleIdList><ArticleId IdType="pubmed">30919621</ArticleId></ArticleIdList></Reference><Reference><Citation>Geiger T, Wehner A, Schaab C, Cox J, Mann M. Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins. Mol Cell Proteomics. 2012;11(3):M111 014050. doi: 10.1074/mcp.M111.014050</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M111.014050</ArticleId><ArticleId IdType="pmc">PMC3316730</ArticleId><ArticleId IdType="pubmed">22278370</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagaraj N, Wisniewski JR, Geiger T, Cox J, Kircher M, Kelso J, et al.. Deep proteome and transcriptome mapping of a human cancer cell line. Mol Syst Biol. 2011;7:548. doi: 10.1038/msb.2011.81</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/msb.2011.81</ArticleId><ArticleId IdType="pmc">PMC3261714</ArticleId><ArticleId IdType="pubmed">22068331</ArticleId></ArticleIdList></Reference><Reference><Citation>Dascher C, Balch WE. Dominant inhibitory mutants of ARF1 block endoplasmic reticulum to Golgi transport and trigger disassembly of the Golgi apparatus. J Biol Chem. 1994;269(2):1437–48.</Citation><ArticleIdList><ArticleId IdType="pubmed">8288610</ArticleId></ArticleIdList></Reference><Reference><Citation>Geller R, Vignuzzi M, Andino R, Frydman J. Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance. Genes Dev. 2007;21(2):195–205. doi: 10.1101/gad.1505307</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1505307</ArticleId><ArticleId IdType="pmc">PMC1770902</ArticleId><ArticleId IdType="pubmed">17234885</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford Siltz LA, Viktorova EG, Zhang B, Kouiavskaia D, Dragunsky E, Chumakov K, et al.. New small-molecule inhibitors effectively blocking picornavirus replication. J Virol. 2014;88(19):11091–107. doi: 10.1128/JVI.01877-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01877-14</ArticleId><ArticleId IdType="pmc">PMC4178779</ArticleId><ArticleId IdType="pubmed">25008939</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern A, Yeh MT, Zinger T, Smith M, Wright C, Ling G, et al.. The Evolutionary Pathway to Virulence of an RNA Virus. Cell. 2017;169(1):35–+. doi: 10.1016/j.cell.2017.03.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.03.013</ArticleId><ArticleId IdType="pmc">PMC5787669</ArticleId><ArticleId IdType="pubmed">28340348</ArticleId></ArticleIdList></Reference><Reference><Citation>Valesano AL, Taniuchi M, Fitzsimmons WJ, Islam MO, Ahmed T, Zaman K, et al.. The Early Evolution of Oral Poliovirus Vaccine Is Shaped by Strong Positive Selection and Tight Transmission Bottlenecks. Cell Host Microbe. 2021;29(1):32–43 e4. doi: 10.1016/j.chom.2020.10.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.10.011</ArticleId><ArticleId IdType="pmc">PMC7815045</ArticleId><ArticleId IdType="pubmed">33212020</ArticleId></ArticleIdList></Reference><Reference><Citation>Echeverri A, Banerjee R, Dasgupta A. Amino-terminal region of poliovirus 2C protein is sufficient for membrane binding. Virus Res. 1998;54(2):217–23. doi: 10.1016/s0168-1702(98)00016-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0168-1702(98)00016-1</ArticleId><ArticleId IdType="pubmed">9696129</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez PL, Carrasco L. Poliovirus protein 2C contains two regions involved in RNA binding activity. J Biol Chem. 1995;270(17):10105–12. doi: 10.1074/jbc.270.17.10105</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.270.17.10105</ArticleId><ArticleId IdType="pubmed">7730315</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan H, Tian J, Qin B, Wojdyla JA, Wang B, Zhao Z, et al.. Crystal structure of 2C helicase from enterovirus 71. Sci Adv. 2017;3(4):e1602573. doi: 10.1126/sciadv.1602573</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1602573</ArticleId><ArticleId IdType="pmc">PMC5409451</ArticleId><ArticleId IdType="pubmed">28508043</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan H, Tian J, Zhang C, Qin B, Cui S. Crystal structure of a soluble fragment of poliovirus 2CATPase. Plos Pathog. 2018;14(9):e1007304. doi: 10.1371/journal.ppat.1007304</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007304</ArticleId><ArticleId IdType="pmc">PMC6166989</ArticleId><ArticleId IdType="pubmed">30231078</ArticleId></ArticleIdList></Reference><Reference><Citation>Zell R, Delwart E, Gorbalenya AE, Hovi T, King AMQ, Knowles NJ, et al.. ICTV Virus Taxonomy Profile: Picornaviridae. J Gen Virol. 2017;98(10):2421–2. doi: 10.1099/jgv.0.000911</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000911</ArticleId><ArticleId IdType="pmc">PMC5725991</ArticleId><ArticleId IdType="pubmed">28884666</ArticleId></ArticleIdList></Reference><Reference><Citation>Norder H, De Palma AM, Selisko B, Costenaro L, Papageorgiou N, Arnan C, et al.. Picornavirus non-structural proteins as targets for new anti-virals with broad activity. Antiviral Res. 2011;89(3):204–18. doi: 10.1016/j.antiviral.2010.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2010.12.007</ArticleId><ArticleId IdType="pubmed">21236302</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazina EV, Mackenzie JM, Gorrell RJ, Anderson DA. Differential requirements for COPI coats in formation of replication complexes among three genera of Picornaviridae. J Virol. 2002;76(21):11113–22. doi: 10.1128/jvi.76.21.11113-11122.2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.76.21.11113-11122.2002</ArticleId><ArticleId IdType="pmc">PMC136594</ArticleId><ArticleId IdType="pubmed">12368353</ArticleId></ArticleIdList></Reference><Reference><Citation>Midgley R, Moffat K, Berryman S, Hawes P, Simpson J, Fullen D, et al.. A role for endoplasmic reticulum exit sites in foot-and-mouth disease virus infection. J Gen Virol. 2013;94(Pt 12):2636–46. doi: 10.1099/vir.0.055442-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.055442-0</ArticleId><ArticleId IdType="pmc">PMC3836498</ArticleId><ArticleId IdType="pubmed">23963534</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JP, Baltimore D. Isolation of poliovirus 2C mutants defective in viral RNA synthesis. J Virol. 1988;62(11):4016–21. doi: 10.1128/JVI.62.11.4016-4021.1988</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.62.11.4016-4021.1988</ArticleId><ArticleId IdType="pmc">PMC253830</ArticleId><ArticleId IdType="pubmed">2845120</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirzayan C, Wimmer E. Genetic analysis of an NTP-binding motif in poliovirus polypeptide 2C. Virology. 1992;189(2):547–55. doi: 10.1016/0042-6822(92)90578-d</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(92)90578-d</ArticleId><ArticleId IdType="pubmed">1322588</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton DJ, Flanegan JB. Synchronous replication of poliovirus RNA: initiation of negative-strand RNA synthesis requires the guanidine-inhibited activity of protein 2C. J Virol. 1997;71(11):8482–9. doi: 10.1128/JVI.71.11.8482-8489.1997</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.71.11.8482-8489.1997</ArticleId><ArticleId IdType="pmc">PMC192311</ArticleId><ArticleId IdType="pubmed">9343205</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance LM, Moscufo N, Chow M, Heinz BA. Poliovirus 2C region functions during encapsidation of viral RNA. J Virol. 1997;71(11):8759–65. doi: 10.1128/JVI.71.11.8759-8765.1997</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.71.11.8759-8765.1997</ArticleId><ArticleId IdType="pmc">PMC192341</ArticleId><ArticleId IdType="pubmed">9343235</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Wang C, Mueller S, Paul AV, Wimmer E, Jiang P. Direct interaction between two viral proteins, the nonstructural protein 2C and the capsid protein VP3, is required for enterovirus morphogenesis. Plos Pathog. 2010;6(8):e1001066. doi: 10.1371/journal.ppat.1001066</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001066</ArticleId><ArticleId IdType="pmc">PMC2928791</ArticleId><ArticleId IdType="pubmed">20865167</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee R, Weidman MK, Echeverri A, Kundu P, Dasgupta A. Regulation of poliovirus 3C protease by the 2C polypeptide. J Virol. 2004;78(17):9243–56. doi: 10.1128/JVI.78.17.9243-9256.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.17.9243-9256.2004</ArticleId><ArticleId IdType="pmc">PMC506913</ArticleId><ArticleId IdType="pubmed">15308719</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin J, Liu Y, Wimmer E, Paul AV. Complete protein linkage map between the P2 and P3 non-structural proteins of poliovirus. J Gen Virol. 2007;88(Pt 8):2259–67. doi: 10.1099/vir.0.82795-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.82795-0</ArticleId><ArticleId IdType="pubmed">17622630</ArticleId></ArticleIdList></Reference><Reference><Citation>Teterina NL, Levenson E, Rinaudo MS, Egger D, Bienz K, Gorbalenya AE, et al.. Evidence for functional protein interactions required for poliovirus RNA replication. J Virol. 2006;80(11):5327–37. doi: 10.1128/JVI.02684-05</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02684-05</ArticleId><ArticleId IdType="pmc">PMC1472133</ArticleId><ArticleId IdType="pubmed">16699013</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang WF, Yang SY, Wu BW, Jheng JR, Chen YL, Shih CH, et al.. Reticulon 3 binds the 2C protein of enterovirus 71 and is required for viral replication. J Biol Chem. 2007;282(8):5888–98. doi: 10.1074/jbc.M611145200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M611145200</ArticleId><ArticleId IdType="pubmed">17182608</ArticleId></ArticleIdList></Reference><Reference><Citation>Itzhak DN, Tyanova S, Cox J, Borner GH. Global, quantitative and dynamic mapping of protein subcellular localization. Elife. 2016;5. doi: 10.7554/eLife.16950</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.16950</ArticleId><ArticleId IdType="pmc">PMC4959882</ArticleId><ArticleId IdType="pubmed">27278775</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams P, Kandiah E, Effantin G, Steven AC, Ehrenfeld E. Poliovirus 2C protein forms homo-oligomeric structures required for ATPase activity. J Biol Chem. 2009;284(33):22012–21. doi: 10.1074/jbc.M109.031807</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.031807</ArticleId><ArticleId IdType="pmc">PMC2755925</ArticleId><ArticleId IdType="pubmed">19520852</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeager C, Carter G, Gohara DW, Yennawar NH, Enemark EJ, Arnold JJ, et al.. Enteroviral 2C protein is an RNA-stimulated ATPase and uses a two-step mechanism for binding to RNA and ATP. Nucleic Acids Res. 2022;50(20):11775–98. doi: 10.1093/nar/gkac1054</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac1054</ArticleId><ArticleId IdType="pmc">PMC9723501</ArticleId><ArticleId IdType="pubmed">36399514</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels E, Duijsings D, Lanke KH, van Dooren SH, Jackson CL, Melchers WJ, et al.. Effects of picornavirus 3A Proteins on Protein Transport and GBF1-dependent COP-I recruitment. J Virol. 2006;80(23):11852–60. doi: 10.1128/JVI.01225-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01225-06</ArticleId><ArticleId IdType="pmc">PMC1642585</ArticleId><ArticleId IdType="pubmed">17005635</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels E, Duijsings D, Niu TK, Neumann S, Oorschot VM, de Lange F, et al.. A viral protein that blocks Arf1-mediated COP-I assembly by inhibiting the guanine nucleotide exchange factor GBF1. Dev Cell. 2006;11(2):191–201. doi: 10.1016/j.devcel.2006.06.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2006.06.005</ArticleId><ArticleId IdType="pubmed">16890159</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghimi S, Viktorova EG, Gabaglio S, Zimina A, Budnik B, Wynn BG, et al.. A Proximity biotinylation assay with a host protein bait reveals multiple factors modulating enterovirus replication. Plos Pathog. 2022;18(10):e1010906. doi: 10.1371/journal.ppat.1010906</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010906</ArticleId><ArticleId IdType="pmc">PMC9645661</ArticleId><ArticleId IdType="pubmed">36306280</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee S, Aponte-Diaz D, Yeager C, Sharma SD, Ning G, Oh HS, et al.. Hijacking of multiple phospholipid biosynthetic pathways and induction of membrane biogenesis by a picornaviral 3CD protein. Plos Pathog. 2018;14(5):e1007086. doi: 10.1371/journal.ppat.1007086</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007086</ArticleId><ArticleId IdType="pmc">PMC5983871</ArticleId><ArticleId IdType="pubmed">29782554</ArticleId></ArticleIdList></Reference><Reference><Citation>Belov GA, Habbersett C, Franco D, Ehrenfeld E. Activation of cellular Arf GTPases by poliovirus protein 3CD correlates with virus replication. J Virol. 2007;81(17):9259–67. doi: 10.1128/JVI.00840-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00840-07</ArticleId><ArticleId IdType="pmc">PMC1951455</ArticleId><ArticleId IdType="pubmed">17567696</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>